vers la météo de la validation par utilisateur
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,activity) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,activity) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,activity) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,activity) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,activity) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,activity) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+---------OBJ:V-N--------+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-------------OBJ:V-N------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | | +----SUBJ:V-N----+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+---------OBJ:V-N--------+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +------------------OBJ:V-N------------------+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +----SUBJ:V-N----+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-------------OBJ:V-N------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | | +----SUBJ:V-N----+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +------------------OBJ:V-N------------------+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +----SUBJ:V-N----+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-------------OBJ:V-N------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V_PASS-N---------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +------------------OBJ:V-N------------------+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-------------OBJ:V-N------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +------------------OBJ:V-N------------------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +-------------OBJ:V-N------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | | +----SUBJ:V-N----+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +-------------OBJ:V-N------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | | +----SUBJ:V-N----+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein) COMP:V-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ +----------------------COMP:N-N(by)----------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ +----------------------COMP:N-N(by)----------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +------------------OBJ:V-N------------------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,protein) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,protein) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-------------OBJ:V-N------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V-N--------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,activity) SUBJ:V_PASS-N (decrease,activity) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-------------OBJ:V-N------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V-N--------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,activity) SUBJ:V_PASS-N (decrease,activity) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +------------------------------------COMP:V-N(by)------------------------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V-N--------------+ | | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,activity) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V-N--------------+ | | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,activity) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V-N--------------+ | | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,activity) SUBJ:V_PASS-N (decrease,activity) COMP:V_PASS-N(by) (decrease,__NODE__)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V-N--------------+ | | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:V_PASS-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,activity) SUBJ:V_PASS-N (decrease,activity) COMP:V_PASS-N(by) (decrease,__NODE__)
+------------------------------------COMP:V-N(by)------------------------------------+ +-------------------------------------------COMP:V-N(In)------------------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V-N--------------+ | | | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) COMP:V-N(by) (increase,__NODE__) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,activity) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+---------COMP:N-N(by)--------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+---------COMP:N-N(by)--------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ +----------------------COMP:N-N(by)----------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V-N--------------+ | | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,activity) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ +----------------------COMP:N-N(by)----------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | | +--------------------OBJ:V-N--------------------+ | +---------------SUBJ:V-N--------------+ | | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,activity) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+ | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,__NODE__) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+---------COMP:N-N(by)--------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ +----------------------COMP:N-N(by)----------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +---------------SUBJ:V_PASS-N---------------+ | | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+-------COMP:N-N(of)-------+ | | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,protein) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (decrease,activity)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-------------COMP:N-N(by)------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,__NODE__) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +-------------COMP:N-N(by)------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-----------------COMP:N-N(by)----------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (__SP__,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +-----------------COMP:N-N(by)----------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-------------OBJ:V-N------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (__SP__,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-------------COMP:N-N(by)------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,__NODE__) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +-------------COMP:N-N(by)------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-----------------COMP:N-N(by)----------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (__SP__,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +-----------------COMP:N-N(by)----------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+ +-------------OBJ:V-N------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (__SP__,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +------------------OBJ:V-N------------------+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ | | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +------------------OBJ:V-N------------------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ | | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ | +----------------------COMP:N-N(by)----------------------+ | | | +-------------COMP:N-N(of)------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) COMP:N-N(of) (nmol/kg/day,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +-------------COMP:N-N(by)------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,__NODE__) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +-------------COMP:N-N(by)------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +-------------COMP:N-N(by)------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,__NODE__) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +-------------COMP:N-N(by)------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +---------OBJ:V-N--------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,__NODE__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+ +-----------------COMP:N-N(by)----------------+ +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +-------------OBJ:V-N------------+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (__SP__,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (decrease,__SP__) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ +MOD_ATT:N-+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) MOD_ATT:N-N (ciglitazone,kidney) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ | +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(o+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__SP__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
+-------------------------------------------COMP:V-N(In)------------------------------------------+ | +------------------------------------SUBJ:V-N-----------------------------------+ +----------------------COMP:N-N(by)----------------------+ | | +--------------------OBJ:V-N--------------------+ +----------OBJ:V-N----------+------------------OBJ:V-N------------------+ | +-----MOD_ATT:N-ADJ----+ | +-------OBJ:V-N-------+ +COMP:N-N(of+ +--COMP:V-N(by)--+ +---COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_ATT:N-N+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ . MOD_ATT:N-ADJ (__SP__,preglomerular) MOD_ATT:N-N (__SP__,artery) OBJ:V-N (with,nmol/kg/day) OBJ:V-N (with,period) COMP:N-N(of) (dosage,9) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,@card@) COMP:V-N(In) (increase,__SP__) SUBJ:V-N (increase,ciglitazone) COMP:V-N(by) (increase,percent) OBJ:V-N (increase,activity) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (activity,__NODE__) COMP:N-N(by) (activity,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (decrease,activity) SUBJ:V-N (decrease,protein)
